IP6K1 was also shown to play a vital role in regulating bone marrow mesenchymal stem cells in mice, in which IP6K1 is identified as a therapeutic target to avoid skeletal involution (continuous bone loss) in response to high-fat diet and obesity (70). Here, IP6K1 is linked to obesity due to melanocortin 4 receptor deficiency.